Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
2019 · Cancer Cell · 254 citations
https://doi.org/10.1016/j.ccell.2019.05.013
K
Khurum Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.5K
Citations
18
h-index
27
i10-index
Khurum Khan is an academic researcher from University College Hospital. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & COVID-19 and healthcare impacts. The author has an h-index of 18, co-authored 54 publications.
ORCID: 0000-0003-1887-629XPapers by this author
worksChallenges in the treatment of gastric cancer in the older patient
2020 · Cancer Treatment Reviews · 155 citations
https://doi.org/10.1016/j.ctrv.2020.101980
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer
2020 · Cancer Treatment Reviews · 12 citations
https://doi.org/10.1016/j.ctrv.2020.102020
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · The Lancet Infectious Diseases · 5 citations
https://doi.org/10.1016/s1473-3099(25)00093-3
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · EClinicalMedicine · 3 citations
https://doi.org/10.1016/j.eclinm.2025.103080
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat